BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy8502
(168 letters)
Database: swissprot
539,616 sequences; 191,569,459 total letters
Searching..................................................done
>sp|O02836|NPY2R_PIG Neuropeptide Y receptor type 2 OS=Sus scrofa GN=NPY2R PE=2 SV=2
Length = 382
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 38/60 (63%), Positives = 46/60 (76%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V I I+ Y ++ L+G+VGNSLVI VVI+ MR VTN+FI NLAVAD+LV TLCLP TL
Sbjct: 50 VQIILILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTL 109
>sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens GN=NPFFR2 PE=1 SV=2
Length = 522
Score = 75.1 bits (183), Expect = 2e-13, Method: Composition-based stats.
Identities = 32/70 (45%), Positives = 47/70 (67%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y H P V FII Y +F + ++GN++V +V+R+ M VTN FI+NLA++D+LV
Sbjct: 140 YLHQPQVAAIFIISYFLIFFLCMMGNTVVCFIVMRNKHMHTVTNLFILNLAISDLLVGIF 199
Query: 148 CLPATLMANI 157
C+P TL+ NI
Sbjct: 200 CMPITLLDNI 209
>sp|P79113|NPY2R_BOVIN Neuropeptide Y receptor type 2 OS=Bos taurus GN=NPY2R PE=2 SV=1
Length = 384
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 36/60 (60%), Positives = 46/60 (76%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V + I+ Y ++ L+G++GNSLVI VVI+ MR VTN+FI NLAVAD+LV TLCLP TL
Sbjct: 52 VQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTL 111
>sp|Q9Z2D5|NPY2R_CAVPO Neuropeptide Y receptor type 2 OS=Cavia porcellus GN=NPY2R PE=3
SV=1
Length = 381
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 37/60 (61%), Positives = 46/60 (76%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V + I+ Y ++ L+G+VGNSLVI VVI+ MR VTN+FI NLAVAD+LV TLCLP TL
Sbjct: 50 VRVVLILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTL 109
>sp|P97295|NPY2R_MOUSE Neuropeptide Y receptor type 2 OS=Mus musculus GN=Npy2r PE=2 SV=2
Length = 381
Score = 74.3 bits (181), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 37/60 (61%), Positives = 46/60 (76%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V + I+ Y ++ L+G+VGNSLVI VVI+ MR VTN+FI NLAVAD+LV TLCLP TL
Sbjct: 49 VQVILILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTL 108
>sp|Q5IS62|NPY2R_PANTR Neuropeptide Y receptor type 2 OS=Pan troglodytes GN=NPY2R PE=2
SV=1
Length = 381
Score = 74.3 bits (181), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 36/60 (60%), Positives = 46/60 (76%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V + I+ Y ++ L+G++GNSLVI VVI+ MR VTN+FI NLAVAD+LV TLCLP TL
Sbjct: 49 VQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTL 108
>sp|P49146|NPY2R_HUMAN Neuropeptide Y receptor type 2 OS=Homo sapiens GN=NPY2R PE=2 SV=1
Length = 381
Score = 74.3 bits (181), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 36/60 (60%), Positives = 46/60 (76%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V + I+ Y ++ L+G++GNSLVI VVI+ MR VTN+FI NLAVAD+LV TLCLP TL
Sbjct: 49 VQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTL 108
>sp|P56718|OX1R_RAT Orexin receptor type 1 OS=Rattus norvegicus GN=Hcrtr1 PE=2 SV=1
Length = 416
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 36/59 (61%), Positives = 46/59 (77%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANI 157
I Y+AVFLI LVGN+LV V R+ MR VTNYFIVNL++AD+LV +CLPA+L+ +I
Sbjct: 50 IAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDI 108
>sp|P58307|OX1R_MOUSE Orexin receptor type 1 OS=Mus musculus GN=Hcrtr1 PE=2 SV=3
Length = 416
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 36/59 (61%), Positives = 46/59 (77%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANI 157
I Y+AVFLI LVGN+LV V R+ MR VTNYFIVNL++AD+LV +CLPA+L+ +I
Sbjct: 50 IAAYVAVFLIALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDI 108
>sp|Q9DDN6|NPY2R_CHICK Neuropeptide Y receptor type 2 OS=Gallus gallus GN=NPY2R PE=3 SV=1
Length = 385
Score = 73.6 bits (179), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 36/61 (59%), Positives = 46/61 (75%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V I I Y ++ L+G++GNSLVI V+I+ MR VTN+FI NLAVAD+LV TLCLP TL
Sbjct: 53 VQIILIFAYCSIILLGVIGNSLVIHVIIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTL 112
Query: 154 M 154
+
Sbjct: 113 V 113
>sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus GN=Npffr2 PE=2 SV=1
Length = 417
Score = 73.2 bits (178), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 35/70 (50%), Positives = 47/70 (67%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y H P VT FI Y +F + +VGN++V VVIR+ M VTN+FI NLA++D+LV
Sbjct: 38 YLHQPHVTAVFISSYFLIFFLCMVGNTVVCFVVIRNRYMHTVTNFFIFNLAISDLLVGIF 97
Query: 148 CLPATLMANI 157
C+P TL+ NI
Sbjct: 98 CMPITLLDNI 107
>sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus GN=Npffr2 PE=2 SV=2
Length = 417
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 34/70 (48%), Positives = 49/70 (70%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y H P V FI YL +F++ +VGN++V +VIR+ M VTN+FI+NLA++D+LV
Sbjct: 38 YLHQPQVAAVFISSYLLIFVLCMVGNTVVCFIVIRNRHMHTVTNFFILNLAISDLLVGIF 97
Query: 148 CLPATLMANI 157
C+P TL+ NI
Sbjct: 98 CMPITLLDNI 107
>sp|Q9GK74|NPY2R_MACMU Neuropeptide Y receptor type 2 OS=Macaca mulatta GN=NPY2R PE=2 SV=1
Length = 381
Score = 72.8 bits (177), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 35/60 (58%), Positives = 46/60 (76%)
Query: 94 VTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATL 153
V + I+ Y ++ L+G++GNSLVI VVI+ MR VTN+FI NLAVAD++V TLCLP TL
Sbjct: 49 VQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFFIANLAVADLVVNTLCLPFTL 108
>sp|Q0GBZ5|OX1R_BOVIN Orexin receptor type 1 OS=Bos taurus GN=HCRTR1 PE=2 SV=1
Length = 425
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 34/59 (57%), Positives = 45/59 (76%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANI 157
I Y+AVF + LVGN+LV V R+ MR VTNYFIVNL++AD+LV +CLPA+L+ +I
Sbjct: 50 IAAYVAVFFVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDI 108
>sp|Q9TUP7|OX2R_CANFA Orexin receptor type 2 OS=Canis familiaris GN=HCRTR2 PE=1 SV=1
Length = 444
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 36/70 (51%), Positives = 46/70 (65%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y H I GY+ VF++ LVGN LV V ++ MR VTNYFIVNL++AD+LV
Sbjct: 47 YLHPKEYEWVLIAGYIIVFVVALVGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTIT 106
Query: 148 CLPATLMANI 157
CLPATL+ +I
Sbjct: 107 CLPATLVVDI 116
>sp|P58308|OX2R_MOUSE Orexin receptor type 2 OS=Mus musculus GN=Hcrtr2 PE=2 SV=2
Length = 460
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 35/70 (50%), Positives = 46/70 (65%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y H I GY+ VF++ L+GN LV V ++ MR VTNYFIVNL++AD+LV
Sbjct: 47 YLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTIT 106
Query: 148 CLPATLMANI 157
CLPATL+ +I
Sbjct: 107 CLPATLVVDI 116
>sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus GN=Npffr1 PE=1 SV=1
Length = 432
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 34/70 (48%), Positives = 50/70 (71%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y+HS V FI Y+ +FL+ +VGN+LV +V+++ MR VTN FI+NLAV+D+LV
Sbjct: 36 YQHSSPVAAMFIAAYVLIFLLCMVGNTLVCFIVLKNRHMRTVTNMFILNLAVSDLLVGIF 95
Query: 148 CLPATLMANI 157
C+P TL+ N+
Sbjct: 96 CMPTTLVDNL 105
>sp|P56719|OX2R_RAT Orexin receptor type 2 OS=Rattus norvegicus GN=Hcrtr2 PE=2 SV=1
Length = 460
Score = 70.9 bits (172), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 35/70 (50%), Positives = 46/70 (65%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y H I GY+ VF++ L+GN LV V ++ MR VTNYFIVNL++AD+LV
Sbjct: 47 YLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTIT 106
Query: 148 CLPATLMANI 157
CLPATL+ +I
Sbjct: 107 CLPATLVVDI 116
>sp|O43614|OX2R_HUMAN Orexin receptor type 2 OS=Homo sapiens GN=HCRTR2 PE=2 SV=2
Length = 444
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 35/70 (50%), Positives = 46/70 (65%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y H I GY+ VF++ L+GN LV V ++ MR VTNYFIVNL++AD+LV
Sbjct: 47 YLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTIT 106
Query: 148 CLPATLMANI 157
CLPATL+ +I
Sbjct: 107 CLPATLVVDI 116
>sp|Q9GZQ6|NPFF1_HUMAN Neuropeptide FF receptor 1 OS=Homo sapiens GN=NPFFR1 PE=2 SV=1
Length = 430
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 32/70 (45%), Positives = 49/70 (70%)
Query: 88 YRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
Y+H+ V FI+ Y +FL+ +VGN+LV +V+++ M VTN FI+NLAV+D+LV
Sbjct: 36 YQHTSPVAAMFIVAYALIFLLCMVGNTLVCFIVLKNRHMHTVTNMFILNLAVSDLLVGIF 95
Query: 148 CLPATLMANI 157
C+P TL+ N+
Sbjct: 96 CMPTTLVDNL 105
>sp|P83858|QRFPR_RAT Pyroglutamylated RFamide peptide receptor OS=Rattus norvegicus
GN=Qrfpr PE=2 SV=1
Length = 433
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 33/74 (44%), Positives = 45/74 (60%), Gaps = 4/74 (5%)
Query: 84 PELLYRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADML 143
PEL R + F + +F + L GNSLVI VV RS MR VTN FI +LA++D+L
Sbjct: 38 PELPAR----AKVAFALAGALIFALALFGNSLVIYVVTRSKAMRTVTNIFICSLALSDLL 93
Query: 144 VITLCLPATLMANI 157
+ C+P T++ NI
Sbjct: 94 IAFFCIPVTMLQNI 107
>sp|P83861|QRFPR_MOUSE Pyroglutamylated RFamide peptide receptor OS=Mus musculus GN=Qrfpr
PE=2 SV=1
Length = 433
Score = 63.2 bits (152), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 33/74 (44%), Positives = 45/74 (60%), Gaps = 4/74 (5%)
Query: 84 PELLYRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADML 143
PEL R + F + +F + L GNSLVI VV RS MR VTN FI +LA++D+L
Sbjct: 38 PELPAR----AKLAFALAGALIFALALFGNSLVIYVVTRSKAMRTVTNIFICSLALSDLL 93
Query: 144 VITLCLPATLMANI 157
+ C+P T++ NI
Sbjct: 94 IAFFCIPVTMLQNI 107
>sp|Q5D0K2|CCKAR_CANFA Cholecystokinin receptor type A OS=Canis familiaris GN=CCKAR PE=2
SV=1
Length = 428
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 31/78 (39%), Positives = 48/78 (61%), Gaps = 3/78 (3%)
Query: 84 PELLYRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADML 143
P P V I Y +FL+ ++GN+LVI V+IR+ RMR VTN F+++LAV+D++
Sbjct: 33 PRAAKEWQPAVQILL---YSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLM 89
Query: 144 VITLCLPATLMANIYVHF 161
+ C+P L+ N+ F
Sbjct: 90 LCLFCMPFNLIPNLLKDF 107
>sp|P30551|CCKAR_RAT Cholecystokinin receptor type A OS=Rattus norvegicus GN=Cckar PE=1
SV=1
Length = 444
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 28/63 (44%), Positives = 46/63 (73%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIY 158
I+ Y +FL+ ++GN+LVI V+IR+ RMR VTN F+++LAV+D+++ C+P L+ N+
Sbjct: 60 ILLYSIIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLL 119
Query: 159 VHF 161
F
Sbjct: 120 KDF 122
>sp|P32238|CCKAR_HUMAN Cholecystokinin receptor type A OS=Homo sapiens GN=CCKAR PE=1 SV=1
Length = 428
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 28/63 (44%), Positives = 46/63 (73%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIY 158
I+ Y +FL+ ++GN+LVI V+IR+ RMR VTN F+++LAV+D+++ C+P L+ N+
Sbjct: 45 ILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLL 104
Query: 159 VHF 161
F
Sbjct: 105 KDF 107
>sp|O08786|CCKAR_MOUSE Cholecystokinin receptor type A OS=Mus musculus GN=Cckar PE=2 SV=1
Length = 436
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 28/63 (44%), Positives = 46/63 (73%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIY 158
I+ Y +FL+ ++GN+LVI V+IR+ RMR VTN F+++LAV+D+++ C+P L+ N+
Sbjct: 45 ILLYSFIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLL 104
Query: 159 VHF 161
F
Sbjct: 105 KDF 107
>sp|P70031|CCKAR_XENLA Cholecystokinin receptor OS=Xenopus laevis GN=cckar PE=2 SV=1
Length = 453
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 41/117 (35%), Positives = 66/117 (56%), Gaps = 15/117 (12%)
Query: 56 NTSGRLTGTLDLLPALTHNLTLNTTSGVPE-------LLYRHSPGVT----ITFIIGYLA 104
N SG LT L THNLT T+ P +L R P + I+ Y
Sbjct: 22 NLSGTLTWNLSSTNG-THNLT---TANWPPWNLNCTPILDRKKPSPSDLNLWVRIVMYSV 77
Query: 105 VFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHF 161
+FL+ + GN+L+I V++ + R+R +TN F+++LA++D++V LC+P TL+ N+ +F
Sbjct: 78 IFLLSVFGNTLIIIVLVMNKRLRTITNSFLLSLALSDLMVAVLCMPFTLIPNLMENF 134
>sp|O97772|CCKAR_RABIT Cholecystokinin receptor type A OS=Oryctolagus cuniculus GN=CCKAR
PE=2 SV=1
Length = 427
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 27/63 (42%), Positives = 46/63 (73%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIY 158
I+ Y +FL+ ++GN+LVI V+IR+ RMR VTN F+++LA++D+++ C+P L+ N+
Sbjct: 45 ILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAISDLMLCLFCMPFNLIPNLL 104
Query: 159 VHF 161
F
Sbjct: 105 KDF 107
>sp|Q04573|NPY1R_MOUSE Neuropeptide Y receptor type 1 OS=Mus musculus GN=Npy1r PE=2 SV=1
Length = 382
Score = 60.1 bits (144), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 73 HNLTLNTTSGVPELLYR----HSP-GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMR 127
H++ N + P L + H P V T + Y AV ++G+ GN +I ++++ MR
Sbjct: 12 HSIHYNASENSPLLAFENDDCHLPLAVIFTLALAYGAVIILGVSGNLALIIIILKQKEMR 71
Query: 128 NVTNYFIVNLAVADMLVITLCLPATLMANIYVHF 161
NVTN IVNL+ +D+LV +CLP T + + H+
Sbjct: 72 NVTNILIVNLSFSDLLVAVMCLPFTFVYTLMDHW 105
>sp|Q96P65|QRFPR_HUMAN Pyroglutamylated RFamide peptide receptor OS=Homo sapiens GN=QRFPR
PE=1 SV=2
Length = 431
Score = 58.9 bits (141), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 31/74 (41%), Positives = 46/74 (62%), Gaps = 4/74 (5%)
Query: 84 PELLYRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADML 143
PEL R + +T ++ +F + L GN+LV VV RS MR VTN FI +LA++D+L
Sbjct: 38 PELPGRAKLALVLTGVL----IFALALFGNALVFYVVTRSKAMRTVTNIFICSLALSDLL 93
Query: 144 VITLCLPATLMANI 157
+ C+P T++ NI
Sbjct: 94 ITFFCIPVTMLQNI 107
>sp|P25931|NPYR_DROME Neuropeptide Y receptor OS=Drosophila melanogaster GN=NepYr PE=2
SV=2
Length = 464
Score = 58.9 bits (141), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 38/54 (70%)
Query: 102 YLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMA 155
Y+ +F+ L+GN V +V +PRMR VTNYFI +LA+ D+L+ C+P++ ++
Sbjct: 112 YIPIFIFALIGNGTVCYIVYSTPRMRTVTNYFIASLAIGDILMSFFCVPSSFIS 165
>sp|Q63931|CCKAR_CAVPO Cholecystokinin receptor type A OS=Cavia porcellus GN=CCKAR PE=2
SV=1
Length = 430
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 27/63 (42%), Positives = 46/63 (73%)
Query: 99 IIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIY 158
I+ Y +FL+ ++GN+LVI V+IR+ RMR VTN F+++LAV+D+++ C+P L+ ++
Sbjct: 45 ILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPSLL 104
Query: 159 VHF 161
F
Sbjct: 105 KDF 107
>sp|P21555|NPY1R_RAT Neuropeptide Y receptor type 1 OS=Rattus norvegicus GN=Npy1r PE=2
SV=3
Length = 382
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 78 NTTSGVPELLYR----HSP-GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNY 132
N + P L + H P V T + Y AV ++G+ GN +I ++++ MRNVTN
Sbjct: 17 NVSENSPFLAFENDDCHLPLAVIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNI 76
Query: 133 FIVNLAVADMLVITLCLPATLMANIYVHF 161
IVNL+ +D+LV +CLP T + + H+
Sbjct: 77 LIVNLSFSDLLVAVMCLPFTFVYTLMDHW 105
>sp|O43613|OX1R_HUMAN Orexin receptor type 1 OS=Homo sapiens GN=HCRTR1 PE=2 SV=2
Length = 425
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 27/46 (58%), Positives = 36/46 (78%)
Query: 112 GNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANI 157
GN+LV V R+ MR VTNYFIVNL++AD+LV +CLPA+L+ +I
Sbjct: 63 GNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDI 108
>sp|P34993|SSR2_BOVIN Somatostatin receptor type 2 OS=Bos taurus GN=SSTR2 PE=2 SV=1
Length = 368
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 69 PALTHNLTLNTTSGVP------ELLYRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIR 122
P LT LN + G E Y + V +TFI Y V +IGL GN+LVI V++R
Sbjct: 12 PWLTTPFDLNGSVGAANISNQTEPYYDLASNVVLTFI--YFVVCIIGLCGNTLVIYVILR 69
Query: 123 SPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHF 161
+M+ +TN +I+NLA+AD L + L LP M VH+
Sbjct: 70 YAKMKTITNIYILNLAIADELFM-LGLPFLAMQVALVHW 107
>sp|Q9WVD0|NPY1R_CAVPO Neuropeptide Y receptor type 1 OS=Cavia porcellus GN=NPY1R PE=3
SV=1
Length = 383
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 29/73 (39%), Positives = 45/73 (61%), Gaps = 1/73 (1%)
Query: 90 HSP-GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLC 148
H P V T + Y AV ++G+ GN +I ++++ MRNVTN IVNL+ +D+LV +C
Sbjct: 34 HLPLAVIFTLALAYGAVIILGVSGNLALILIILKQKEMRNVTNILIVNLSFSDLLVAIMC 93
Query: 149 LPATLMANIYVHF 161
LP T + + H+
Sbjct: 94 LPFTFVYTLMDHW 106
>sp|O02813|NPY1R_CANFA Neuropeptide Y receptor type 1 OS=Canis familiaris GN=NPY1R PE=2
SV=2
Length = 382
Score = 56.2 bits (134), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/73 (38%), Positives = 45/73 (61%), Gaps = 1/73 (1%)
Query: 90 HSP-GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLC 148
H P + T + Y AV ++G+ GN +I ++++ MRNVTN IVNL+ +D+LV +C
Sbjct: 33 HLPLAMIFTLALAYGAVIILGVTGNLALIMIILKQKEMRNVTNILIVNLSFSDLLVAIMC 92
Query: 149 LPATLMANIYVHF 161
LP T + + H+
Sbjct: 93 LPFTFVYTLMDHW 105
>sp|P41145|OPRK_HUMAN Kappa-type opioid receptor OS=Homo sapiens GN=OPRK1 PE=1 SV=2
Length = 380
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/56 (50%), Positives = 38/56 (67%)
Query: 91 SPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVIT 146
SP + + Y VF++GLVGNSLV+ V+IR +M+ TN +I NLA+AD LV T
Sbjct: 55 SPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTT 110
>sp|O02835|NPY1R_PIG Neuropeptide Y receptor type 1 OS=Sus scrofa GN=NPY1R PE=2 SV=2
Length = 383
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/73 (38%), Positives = 45/73 (61%), Gaps = 1/73 (1%)
Query: 90 HSP-GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLC 148
H P + T + Y AV ++G+ GN +I ++++ MRNVTN IVNL+ +D+LV +C
Sbjct: 34 HLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLVAIMC 93
Query: 149 LPATLMANIYVHF 161
LP T + + H+
Sbjct: 94 LPFTFVYTLMDHW 106
>sp|P25929|NPY1R_HUMAN Neuropeptide Y receptor type 1 OS=Homo sapiens GN=NPY1R PE=2 SV=1
Length = 384
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/73 (38%), Positives = 45/73 (61%), Gaps = 1/73 (1%)
Query: 90 HSP-GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLC 148
H P + T + Y AV ++G+ GN +I ++++ MRNVTN IVNL+ +D+LV +C
Sbjct: 34 HLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLVAIMC 93
Query: 149 LPATLMANIYVHF 161
LP T + + H+
Sbjct: 94 LPFTFVYTLMDHW 106
>sp|P34975|OPRK_RAT Kappa-type opioid receptor OS=Rattus norvegicus GN=Oprk1 PE=2 SV=1
Length = 380
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/56 (50%), Positives = 38/56 (67%)
Query: 91 SPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVIT 146
SP + + Y VF++GLVGNSLV+ V+IR +M+ TN +I NLA+AD LV T
Sbjct: 55 SPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTT 110
>sp|P33534|OPRK_MOUSE Kappa-type opioid receptor OS=Mus musculus GN=Oprk1 PE=2 SV=1
Length = 380
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 28/56 (50%), Positives = 38/56 (67%)
Query: 91 SPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVIT 146
SP + + Y VF++GLVGNSLV+ V+IR +M+ TN +I NLA+AD LV T
Sbjct: 55 SPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTT 110
>sp|Q1RMU8|NPY1R_BOVIN Neuropeptide Y receptor type 1 OS=Bos taurus GN=NPY1R PE=2 SV=1
Length = 383
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 28/73 (38%), Positives = 45/73 (61%), Gaps = 1/73 (1%)
Query: 90 HSP-GVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLC 148
H P + T + Y AV ++G+ GN +I ++++ MRNVTN IVNL+ +D+LV +C
Sbjct: 34 HLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLVAIMC 93
Query: 149 LPATLMANIYVHF 161
LP T + + H+
Sbjct: 94 LPFTFVYTLMDHW 106
>sp|P34992|NPY1R_XENLA Neuropeptide Y receptor type 1 OS=Xenopus laevis GN=npy1r PE=2 SV=1
Length = 366
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 27/65 (41%), Positives = 42/65 (64%)
Query: 97 TFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMAN 156
T + Y AV ++GL GN +I ++++ MRNVTN IVNL+ +D+L +CLP TL+
Sbjct: 37 TLALAYGAVIILGLSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLATIMCLPFTLIYT 96
Query: 157 IYVHF 161
+ H+
Sbjct: 97 LMDHW 101
>sp|P30680|SSR2_RAT Somatostatin receptor type 2 OS=Rattus norvegicus GN=Sstr2 PE=1
SV=1
Length = 369
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 6/108 (5%)
Query: 57 TSGRLTGTLDLLPA---LTHNLTLNTTSGVPELLYRHSPGVTITFIIGYLAVFLIGLVGN 113
TS + G+ +P+ L +L + S E Y + +TFI Y V ++GL GN
Sbjct: 4 TSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFI--YFVVCVVGLCGN 61
Query: 114 SLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPATLMANIYVHF 161
+LVI V++R +M+ +TN +I+NLA+AD L + L LP M VH+
Sbjct: 62 TLVIYVILRYAKMKTITNIYILNLAIADELFM-LGLPFLAMQVALVHW 108
>sp|P41144|OPRK_CAVPO Kappa-type opioid receptor OS=Cavia porcellus GN=OPRK1 PE=2 SV=1
Length = 380
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 28/56 (50%), Positives = 38/56 (67%)
Query: 91 SPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVIT 146
SP + + Y VF++GLVGNSLV+ V+IR +M+ TN +I NLA+AD LV T
Sbjct: 55 SPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTT 110
>sp|P30874|SSR2_HUMAN Somatostatin receptor type 2 OS=Homo sapiens GN=SSTR2 PE=1 SV=1
Length = 369
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/82 (42%), Positives = 49/82 (59%), Gaps = 3/82 (3%)
Query: 80 TSGVPELLYRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAV 139
TS E Y + +TFI Y V +IGL GN+LVI V++R +M+ +TN +I+NLA+
Sbjct: 30 TSNQTEPYYDLTSNAVLTFI--YFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAI 87
Query: 140 ADMLVITLCLPATLMANIYVHF 161
AD L + L LP M VH+
Sbjct: 88 ADELFM-LGLPFLAMQVALVHW 108
>sp|P79218|NK2R_RABIT Substance-K receptor OS=Oryctolagus cuniculus GN=TACR2 PE=2 SV=1
Length = 384
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 27/57 (47%), Positives = 39/57 (68%), Gaps = 1/57 (1%)
Query: 92 PGVTIT-FIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITL 147
PG + + YLA+ L+ +VGN+ VI +++ RMR VTNYFIVNLA+AD+ + T
Sbjct: 29 PGWQLALWATAYLALVLVAVVGNATVIWIILAHRRMRTVTNYFIVNLALADLCMATF 85
>sp|Q61121|GPR19_MOUSE Probable G-protein coupled receptor 19 OS=Mus musculus GN=Gpr19
PE=2 SV=2
Length = 415
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 28/66 (42%), Positives = 41/66 (62%)
Query: 85 ELLYRHSPGVTITFIIGYLAVFLIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLV 144
EL Y +PG T I + A++L + GNSLV V+ RS R ++ TNYF+V++A AD+L+
Sbjct: 55 ELQYELNPGEVATASIFFGALWLFSIFGNSLVCLVIHRSRRTQSTTNYFVVSMACADLLI 114
Query: 145 ITLCLP 150
P
Sbjct: 115 SVASTP 120
>sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori GN=AR PE=2 SV=1
Length = 361
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 25/46 (54%), Positives = 35/46 (76%)
Query: 107 LIGLVGNSLVIAVVIRSPRMRNVTNYFIVNLAVADMLVITLCLPAT 152
++GLVGN+LV+ VV +P MR+ TN I+NLAVAD+L + C+P T
Sbjct: 54 IVGLVGNALVVLVVAANPGMRSTTNLLIINLAVADLLFVIFCVPFT 99
Database: swissprot
Posted date: Mar 23, 2013 2:32 AM
Number of letters in database: 191,569,459
Number of sequences in database: 539,616
Lambda K H
0.324 0.141 0.410
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 60,330,852
Number of Sequences: 539616
Number of extensions: 2388163
Number of successful extensions: 9439
Number of sequences better than 100.0: 50
Number of HSP's better than 100.0 without gapping: 1514
Number of HSP's successfully gapped in prelim test: 164
Number of HSP's that attempted gapping in prelim test: 7770
Number of HSP's gapped (non-prelim): 1759
length of query: 168
length of database: 191,569,459
effective HSP length: 109
effective length of query: 59
effective length of database: 132,751,315
effective search space: 7832327585
effective search space used: 7832327585
T: 11
A: 40
X1: 15 ( 7.0 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.5 bits)
S2: 57 (26.6 bits)